Related Experiment Videos
Plasma exchange in myasthenia gravis
The International Journal of Artificial Organs
|September 1, 1984
Summary
P.E. therapy rapidly improved most patients with myasthenia gravis (M.G.). This study found P.E. therapy to be a useful treatment for M.G., with 15 out of 19 patients showing improvement.
Area of Science:
- Neurology
- Immunology
Background:
- Myasthenia gravis (M.G.) is a chronic autoimmune neuromuscular disease.
- Current treatments for M.G. aim to manage symptoms and improve quality of life.
Purpose of the Study:
- To evaluate the efficacy of P.E. therapy in patients with myasthenia gravis.
- To determine if P.E. therapy offers a rapid improvement for M.G. patients.
Main Methods:
- The study involved 19 patients diagnosed with myasthenia gravis.
- Patients received P.E. therapy, and outcomes were monitored.
Main Results:
- 15 out of 19 patients (79%) experienced improvement during P.E. therapy.
- 4 patients (21%) showed no change in their condition.
Conclusions:
- P.E. therapy appears to be a beneficial treatment for myasthenia gravis.
- The rapid improvement observed in most patients suggests P.E. therapy is a valuable therapeutic option for M.G.